And what if the WS strategy is for retail longs to be left holding the AFFY bag. Are the retail shareholders to file the quarterly report? It seems to me that no credible entity is looking to obtain control of AFFY. Sophisticated investors, those with money and the ability to buy this worthless company, seem to know better. Of course if AFFY was really being bought ought for $5, $10, $15 or even $20 per share as I have seen lunatic long pumpers tout, I might expect to see a real entity file for a change in Affymax control.
That's right jagan. AFFY trades several times the entire float on the first runup from $1.92 to $4.10, and then trades again more than the entire float on the second runup from $.84 to $1.95. Next you suggest a buyout from Takeda or Amgen or whoever, and there is no change in the stock ownership by 50%. You are a piece of work!